Xenon to Highlight Phase 3 X-TOLE2 & Long-Term Data for Azetukalner in Focal Onset Seizures at 2026 AAN Annual Meeting
· Financial Post
Efficacy & Safety Data for Azetukalner in Focal Onset Seizures Read More
Visit esporist.com for more information.